Correlations between MTP and ROS Levels of Peripheral Blood Lymphocytes and Readmission in Patients with Chronic Heart Failure

Background Peripheral blood lymphocytes exhibit changes that parallel those in failing cardiomyocytes. We hypothesised that mitochondrial transmembrane potential (MTP) and reactive oxygen species (ROS) levels of lymphocytes are associated with serum NT-proBNP and short-term prognosis in patients wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart, lung & circulation lung & circulation, 2016-03, Vol.25 (3), p.296-302
Hauptverfasser: Song, Bingxue, MS, Li, Tao, MD, Chen, Shuping, MS, Yang, Dandan, MS, Luo, Ling, MS, Wang, Tingzhong, PhD, Han, Xiu, MD, Bai, Ling, MD, PhD, Ma, Aiqun, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 302
container_issue 3
container_start_page 296
container_title Heart, lung & circulation
container_volume 25
creator Song, Bingxue, MS
Li, Tao, MD
Chen, Shuping, MS
Yang, Dandan, MS
Luo, Ling, MS
Wang, Tingzhong, PhD
Han, Xiu, MD
Bai, Ling, MD, PhD
Ma, Aiqun, MD, PhD
description Background Peripheral blood lymphocytes exhibit changes that parallel those in failing cardiomyocytes. We hypothesised that mitochondrial transmembrane potential (MTP) and reactive oxygen species (ROS) levels of lymphocytes are associated with serum NT-proBNP and short-term prognosis in patients with chronic heart failure (CHF). Methods Fifty-four CHF patients and 30 controls were enrolled in this prospective study. Mitochondrial transmembrane potential and ROS levels of lymphocytes were evaluated by flow cytometry and reported as the JC-1 fluorescence ratio and DCF fluorescence intensity, respectively. Serum NT-proBNP levels and biochemical parameters were also examined. All the participants received follow-up to evaluate clinical end-points after eight months. Results Chronic heart failure patients had higher levels of DCF fluorescence intensity of lymphocytes and serum NT-proBNP, as well as lower levels of JC-1 fluorescence ratios compared with those of controls (all P
doi_str_mv 10.1016/j.hlc.2015.09.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1767067561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1443950615013943</els_id><sourcerecordid>1767067561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-454f2cf3c085ffe8e0ff81b84aaa673c490b63f79b3e37edb36218a9a3a205873</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEoqXwA7ggH7kk-Cu2IyQkWFGKtKgrWs6W44wVL954sZNWe-G342ULBw6cZg7v-2j0TFW9JLghmIg322YMtqGYtA3uGoz5o-qccM5rqjr6-PfO6q7F4qx6lvMWYyI5655WZ1QIRhSV59XPVUwJgpl9nDLqYb4HmNCX2w0y04C-Xt-gNdxByCg6tIHk9yMkE9CHEOOA1ofdfoz2MEM-xcEMO59zYSE_oU2hwjRndO_nEa3GFCdv0RWYNKNL48OS4Hn1xJmQ4cXDvKi-XX68XV3V6-tPn1fv17XlUs01b7mj1jGLVescKMDOKdIrbowRklne4V4wJ7ueAZMw9ExQokxnmKG4VZJdVK9P3H2KPxbIsy53WgjBTBCXrIkUEgvZClKi5BS1KeacwOl98juTDppgfdSut7po10ftGne6aC-dVw_4pd_B8Lfxx3MJvD0Fikq485B0tsWNhcEnsLMeov8v_t0_bRt8cWnCdzhA3sYlTcWeJjpTjfXN8e_Ht5MWE9Zxxn4BRHeoiA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1767067561</pqid></control><display><type>article</type><title>Correlations between MTP and ROS Levels of Peripheral Blood Lymphocytes and Readmission in Patients with Chronic Heart Failure</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Song, Bingxue, MS ; Li, Tao, MD ; Chen, Shuping, MS ; Yang, Dandan, MS ; Luo, Ling, MS ; Wang, Tingzhong, PhD ; Han, Xiu, MD ; Bai, Ling, MD, PhD ; Ma, Aiqun, MD, PhD</creator><creatorcontrib>Song, Bingxue, MS ; Li, Tao, MD ; Chen, Shuping, MS ; Yang, Dandan, MS ; Luo, Ling, MS ; Wang, Tingzhong, PhD ; Han, Xiu, MD ; Bai, Ling, MD, PhD ; Ma, Aiqun, MD, PhD</creatorcontrib><description>Background Peripheral blood lymphocytes exhibit changes that parallel those in failing cardiomyocytes. We hypothesised that mitochondrial transmembrane potential (MTP) and reactive oxygen species (ROS) levels of lymphocytes are associated with serum NT-proBNP and short-term prognosis in patients with chronic heart failure (CHF). Methods Fifty-four CHF patients and 30 controls were enrolled in this prospective study. Mitochondrial transmembrane potential and ROS levels of lymphocytes were evaluated by flow cytometry and reported as the JC-1 fluorescence ratio and DCF fluorescence intensity, respectively. Serum NT-proBNP levels and biochemical parameters were also examined. All the participants received follow-up to evaluate clinical end-points after eight months. Results Chronic heart failure patients had higher levels of DCF fluorescence intensity of lymphocytes and serum NT-proBNP, as well as lower levels of JC-1 fluorescence ratios compared with those of controls (all P&lt;0.05). A closer relationship was found between Lg(DCF fluorescence intensity of lymphocytes) or JC-1 fluorescence ratio of lymphocytes and Lg(NT-proBNP) (both P &lt;0.05) in CHF patients. During the eight-month follow-up period, 14 CHF patients (25.9%) were readmitted for severe HF, but none died. A logistic regression analysis showed that both ROS level and MTP of the lymphocytes were independent predictors (B=7.03, P =0.006; B= - 0.32, P =0.029, respectively) of readmission of CHF patients. Conclusions In CHF patients at low risk, MTP and ROS levels of the lymphocytes showed a significant change that is associated with serum NT-proBNP and patient readmission.</description><identifier>ISSN: 1443-9506</identifier><identifier>EISSN: 1444-2892</identifier><identifier>DOI: 10.1016/j.hlc.2015.09.004</identifier><identifier>PMID: 26631827</identifier><language>eng</language><publisher>Australia: Elsevier B.V</publisher><subject>Aged ; Cardiovascular ; Chronic Disease ; Chronic heart failure ; Female ; Heart Failure - blood ; Humans ; Lymphocytes - metabolism ; Lymphocytes - pathology ; Male ; Membrane Potential, Mitochondrial ; Middle Aged ; Mitochondrial transmembrane potential ; N-terminal-probrain natriuretic peptide ; Patient Readmission ; Predictive Value of Tests ; Prospective Studies ; Reactive oxygen species ; Reactive Oxygen Species - blood ; Readmission</subject><ispartof>Heart, lung &amp; circulation, 2016-03, Vol.25 (3), p.296-302</ispartof><rights>Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)</rights><rights>2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)</rights><rights>Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-454f2cf3c085ffe8e0ff81b84aaa673c490b63f79b3e37edb36218a9a3a205873</citedby><cites>FETCH-LOGICAL-c478t-454f2cf3c085ffe8e0ff81b84aaa673c490b63f79b3e37edb36218a9a3a205873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.hlc.2015.09.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26631827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Bingxue, MS</creatorcontrib><creatorcontrib>Li, Tao, MD</creatorcontrib><creatorcontrib>Chen, Shuping, MS</creatorcontrib><creatorcontrib>Yang, Dandan, MS</creatorcontrib><creatorcontrib>Luo, Ling, MS</creatorcontrib><creatorcontrib>Wang, Tingzhong, PhD</creatorcontrib><creatorcontrib>Han, Xiu, MD</creatorcontrib><creatorcontrib>Bai, Ling, MD, PhD</creatorcontrib><creatorcontrib>Ma, Aiqun, MD, PhD</creatorcontrib><title>Correlations between MTP and ROS Levels of Peripheral Blood Lymphocytes and Readmission in Patients with Chronic Heart Failure</title><title>Heart, lung &amp; circulation</title><addtitle>Heart Lung Circ</addtitle><description>Background Peripheral blood lymphocytes exhibit changes that parallel those in failing cardiomyocytes. We hypothesised that mitochondrial transmembrane potential (MTP) and reactive oxygen species (ROS) levels of lymphocytes are associated with serum NT-proBNP and short-term prognosis in patients with chronic heart failure (CHF). Methods Fifty-four CHF patients and 30 controls were enrolled in this prospective study. Mitochondrial transmembrane potential and ROS levels of lymphocytes were evaluated by flow cytometry and reported as the JC-1 fluorescence ratio and DCF fluorescence intensity, respectively. Serum NT-proBNP levels and biochemical parameters were also examined. All the participants received follow-up to evaluate clinical end-points after eight months. Results Chronic heart failure patients had higher levels of DCF fluorescence intensity of lymphocytes and serum NT-proBNP, as well as lower levels of JC-1 fluorescence ratios compared with those of controls (all P&lt;0.05). A closer relationship was found between Lg(DCF fluorescence intensity of lymphocytes) or JC-1 fluorescence ratio of lymphocytes and Lg(NT-proBNP) (both P &lt;0.05) in CHF patients. During the eight-month follow-up period, 14 CHF patients (25.9%) were readmitted for severe HF, but none died. A logistic regression analysis showed that both ROS level and MTP of the lymphocytes were independent predictors (B=7.03, P =0.006; B= - 0.32, P =0.029, respectively) of readmission of CHF patients. Conclusions In CHF patients at low risk, MTP and ROS levels of the lymphocytes showed a significant change that is associated with serum NT-proBNP and patient readmission.</description><subject>Aged</subject><subject>Cardiovascular</subject><subject>Chronic Disease</subject><subject>Chronic heart failure</subject><subject>Female</subject><subject>Heart Failure - blood</subject><subject>Humans</subject><subject>Lymphocytes - metabolism</subject><subject>Lymphocytes - pathology</subject><subject>Male</subject><subject>Membrane Potential, Mitochondrial</subject><subject>Middle Aged</subject><subject>Mitochondrial transmembrane potential</subject><subject>N-terminal-probrain natriuretic peptide</subject><subject>Patient Readmission</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - blood</subject><subject>Readmission</subject><issn>1443-9506</issn><issn>1444-2892</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhiMEoqXwA7ggH7kk-Cu2IyQkWFGKtKgrWs6W44wVL954sZNWe-G342ULBw6cZg7v-2j0TFW9JLghmIg322YMtqGYtA3uGoz5o-qccM5rqjr6-PfO6q7F4qx6lvMWYyI5655WZ1QIRhSV59XPVUwJgpl9nDLqYb4HmNCX2w0y04C-Xt-gNdxByCg6tIHk9yMkE9CHEOOA1ofdfoz2MEM-xcEMO59zYSE_oU2hwjRndO_nEa3GFCdv0RWYNKNL48OS4Hn1xJmQ4cXDvKi-XX68XV3V6-tPn1fv17XlUs01b7mj1jGLVescKMDOKdIrbowRklne4V4wJ7ueAZMw9ExQokxnmKG4VZJdVK9P3H2KPxbIsy53WgjBTBCXrIkUEgvZClKi5BS1KeacwOl98juTDppgfdSut7po10ftGne6aC-dVw_4pd_B8Lfxx3MJvD0Fikq485B0tsWNhcEnsLMeov8v_t0_bRt8cWnCdzhA3sYlTcWeJjpTjfXN8e_Ht5MWE9Zxxn4BRHeoiA</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Song, Bingxue, MS</creator><creator>Li, Tao, MD</creator><creator>Chen, Shuping, MS</creator><creator>Yang, Dandan, MS</creator><creator>Luo, Ling, MS</creator><creator>Wang, Tingzhong, PhD</creator><creator>Han, Xiu, MD</creator><creator>Bai, Ling, MD, PhD</creator><creator>Ma, Aiqun, MD, PhD</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160301</creationdate><title>Correlations between MTP and ROS Levels of Peripheral Blood Lymphocytes and Readmission in Patients with Chronic Heart Failure</title><author>Song, Bingxue, MS ; Li, Tao, MD ; Chen, Shuping, MS ; Yang, Dandan, MS ; Luo, Ling, MS ; Wang, Tingzhong, PhD ; Han, Xiu, MD ; Bai, Ling, MD, PhD ; Ma, Aiqun, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-454f2cf3c085ffe8e0ff81b84aaa673c490b63f79b3e37edb36218a9a3a205873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Cardiovascular</topic><topic>Chronic Disease</topic><topic>Chronic heart failure</topic><topic>Female</topic><topic>Heart Failure - blood</topic><topic>Humans</topic><topic>Lymphocytes - metabolism</topic><topic>Lymphocytes - pathology</topic><topic>Male</topic><topic>Membrane Potential, Mitochondrial</topic><topic>Middle Aged</topic><topic>Mitochondrial transmembrane potential</topic><topic>N-terminal-probrain natriuretic peptide</topic><topic>Patient Readmission</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - blood</topic><topic>Readmission</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Bingxue, MS</creatorcontrib><creatorcontrib>Li, Tao, MD</creatorcontrib><creatorcontrib>Chen, Shuping, MS</creatorcontrib><creatorcontrib>Yang, Dandan, MS</creatorcontrib><creatorcontrib>Luo, Ling, MS</creatorcontrib><creatorcontrib>Wang, Tingzhong, PhD</creatorcontrib><creatorcontrib>Han, Xiu, MD</creatorcontrib><creatorcontrib>Bai, Ling, MD, PhD</creatorcontrib><creatorcontrib>Ma, Aiqun, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Heart, lung &amp; circulation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Bingxue, MS</au><au>Li, Tao, MD</au><au>Chen, Shuping, MS</au><au>Yang, Dandan, MS</au><au>Luo, Ling, MS</au><au>Wang, Tingzhong, PhD</au><au>Han, Xiu, MD</au><au>Bai, Ling, MD, PhD</au><au>Ma, Aiqun, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlations between MTP and ROS Levels of Peripheral Blood Lymphocytes and Readmission in Patients with Chronic Heart Failure</atitle><jtitle>Heart, lung &amp; circulation</jtitle><addtitle>Heart Lung Circ</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>25</volume><issue>3</issue><spage>296</spage><epage>302</epage><pages>296-302</pages><issn>1443-9506</issn><eissn>1444-2892</eissn><abstract>Background Peripheral blood lymphocytes exhibit changes that parallel those in failing cardiomyocytes. We hypothesised that mitochondrial transmembrane potential (MTP) and reactive oxygen species (ROS) levels of lymphocytes are associated with serum NT-proBNP and short-term prognosis in patients with chronic heart failure (CHF). Methods Fifty-four CHF patients and 30 controls were enrolled in this prospective study. Mitochondrial transmembrane potential and ROS levels of lymphocytes were evaluated by flow cytometry and reported as the JC-1 fluorescence ratio and DCF fluorescence intensity, respectively. Serum NT-proBNP levels and biochemical parameters were also examined. All the participants received follow-up to evaluate clinical end-points after eight months. Results Chronic heart failure patients had higher levels of DCF fluorescence intensity of lymphocytes and serum NT-proBNP, as well as lower levels of JC-1 fluorescence ratios compared with those of controls (all P&lt;0.05). A closer relationship was found between Lg(DCF fluorescence intensity of lymphocytes) or JC-1 fluorescence ratio of lymphocytes and Lg(NT-proBNP) (both P &lt;0.05) in CHF patients. During the eight-month follow-up period, 14 CHF patients (25.9%) were readmitted for severe HF, but none died. A logistic regression analysis showed that both ROS level and MTP of the lymphocytes were independent predictors (B=7.03, P =0.006; B= - 0.32, P =0.029, respectively) of readmission of CHF patients. Conclusions In CHF patients at low risk, MTP and ROS levels of the lymphocytes showed a significant change that is associated with serum NT-proBNP and patient readmission.</abstract><cop>Australia</cop><pub>Elsevier B.V</pub><pmid>26631827</pmid><doi>10.1016/j.hlc.2015.09.004</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1443-9506
ispartof Heart, lung & circulation, 2016-03, Vol.25 (3), p.296-302
issn 1443-9506
1444-2892
language eng
recordid cdi_proquest_miscellaneous_1767067561
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aged
Cardiovascular
Chronic Disease
Chronic heart failure
Female
Heart Failure - blood
Humans
Lymphocytes - metabolism
Lymphocytes - pathology
Male
Membrane Potential, Mitochondrial
Middle Aged
Mitochondrial transmembrane potential
N-terminal-probrain natriuretic peptide
Patient Readmission
Predictive Value of Tests
Prospective Studies
Reactive oxygen species
Reactive Oxygen Species - blood
Readmission
title Correlations between MTP and ROS Levels of Peripheral Blood Lymphocytes and Readmission in Patients with Chronic Heart Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A52%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlations%20between%20MTP%20and%20ROS%20Levels%20of%20Peripheral%20Blood%20Lymphocytes%20and%20Readmission%20in%20Patients%20with%20Chronic%20Heart%20Failure&rft.jtitle=Heart,%20lung%20&%20circulation&rft.au=Song,%20Bingxue,%20MS&rft.date=2016-03-01&rft.volume=25&rft.issue=3&rft.spage=296&rft.epage=302&rft.pages=296-302&rft.issn=1443-9506&rft.eissn=1444-2892&rft_id=info:doi/10.1016/j.hlc.2015.09.004&rft_dat=%3Cproquest_cross%3E1767067561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1767067561&rft_id=info:pmid/26631827&rft_els_id=1_s2_0_S1443950615013943&rfr_iscdi=true